Literature DB >> 30917950

Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis.

Juliet N Barker1,2, Kirsten Boughan1, Parastoo B Dahi1,2, Sean M Devlin3, Molly A Maloy1, Kristine Naputo1, Christopher M Mazis1, Eric Davis1, Melissa Nhaissi1, Deborah Wells4, Candice Cooper4, Doris M Ponce1,2, Nancy Kernan4, Andromachi Scaradavou4, Sergio A Giralt1,2, Esperanza B Papadopoulos1,2, Ioannis Politikos1.   

Abstract

Availability of 8/8 HLA-allele matched unrelated donors (URDs) is a barrier for ethnic and racial minorities. We prospectively evaluated receipt of 8/8 HLA-allele matched URD or either 7/8 URD or cord blood (CB) transplants by patient ancestry from 2005 to 2017. Matched URDs were given priority if they were available. Of 1312 patients, 723 (55%) received 8/8 URD, 219 (17%) 7/8 URD, 319 (24%) CB, and 51 (4%) had no 7/8 or 8/8 URD or CB graft. Europeans were more likely to receive an 8/8 URD transplant than non-Europeans (67% vs 33%) and less likely to have no URD or CB graft (1% vs 9%). Southern Europeans received 8/8 URD transplants (41%) at rates similar to those of Asians (34%) and white Hispanics (35%); Africans were the least likely (18%) to undergo 8/8 URD transplantation. CB and 7/8 URDs extended transplant access to all groups. In 742 recent patients, marked racial disparity in 8/8 URD access between groups observed in earlier years persisted with only a modest increase in the percentage of 8/8 URD transplants. Of 78 recent African patients, 46% received a CB transplant and 14% had no 7/8 or 8/8 URD or CB graft. Increasing registry size has not resolved the racial disparity in URD access, which emphasizes the importance of alternative graft sources.
© 2019 by The American Society of Hematology.

Entities:  

Year:  2019        PMID: 30917950      PMCID: PMC6457223          DOI: 10.1182/bloodadvances.2018028662

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  21 in total

1.  A perspective on the selection of unrelated donors and cord blood units for transplantation.

Authors:  Stephen R Spellman; Mary Eapen; Brent R Logan; Carlheinz Mueller; Pablo Rubinstein; Michelle I Setterholm; Ann E Woolfrey; Mary M Horowitz; Dennis L Confer; Carolyn K Hurley
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

2.  Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage.

Authors:  R N Lown; S G E Marsh; G E Switzer; K A Latham; J A Madrigal; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

Review 3.  Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.

Authors:  Juliet N Barker; Joanne Kurtzberg; Karen Ballen; Michael Boo; Claudio Brunstein; Corey Cutler; Mitchell Horwitz; Filippo Milano; Amanda Olson; Stephen Spellman; John E Wagner; Colleen Delaney; Elizabeth Shpall
Journal:  Biol Blood Marrow Transplant       Date:  2017-03-06       Impact factor: 5.742

4.  HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research.

Authors:  Michael R Verneris; Stephanie J Lee; Kwang Woo Ahn; Hai-Lin Wang; Minoo Battiwalla; Yoshihiro Inamoto; Marcelo A Fernandez-Vina; James Gajewski; Joseph Pidala; Reinhold Munker; Mahmoud Aljurf; Wael Saber; Stephen Spellman; John Koreth
Journal:  Biol Blood Marrow Transplant       Date:  2015-06-06       Impact factor: 5.742

5.  Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.

Authors:  Juliet N Barker; Courtney E Byam; Nancy A Kernan; Sinda S Lee; Rebecca M Hawke; Kathleen A Doshi; Deborah S Wells; Glenn Heller; Esperanza B Papadopoulos; Andromachi Scaradavou; James W Young; Marcel R M van den Brink
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-25       Impact factor: 5.742

6.  High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis.

Authors:  Daniel Fürst; Carlheinz Müller; Vladan Vucinic; Donald Bunjes; Wolfgang Herr; Martin Gramatzki; Rainer Schwerdtfeger; Renate Arnold; Hermann Einsele; Gerald Wulf; Michael Pfreundschuh; Bertram Glass; Hubert Schrezenmeier; Klaus Schwarz; Joannis Mytilineos
Journal:  Blood       Date:  2013-09-17       Impact factor: 22.113

7.  Race and ethnicity in decisions about unrelated hematopoietic stem cell donation.

Authors:  Galen E Switzer; Jessica G Bruce; Larissa Myaskovsky; Andrea DiMartini; Diana Shellmer; Dennis L Confer; Linda K Abress; Roberta J King; Allyson G Harnaha; Sibylle Ohngemach; Mary Amanda Dew
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

8.  Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors.

Authors:  Craig Kollman; Esteban Abella; Robert L Baitty; Patrick G Beatty; Ranajit Chakraborty; Cindy L Christiansen; Robert J Hartzman; Carolyn Katovich Hurley; Edgar Milford; John A Nyman; Thomas J Smith; Galen E Switzer; Randal K Wada; Michelle Setterholm
Journal:  Transplantation       Date:  2004-07-15       Impact factor: 4.939

9.  8/8 and 10/10 high-resolution match rate for the be the match unrelated donor registry.

Authors:  Jason Dehn; Kelly Buck; Martin Maiers; Dennis Confer; Robert Hartzman; Craig Kollman; Alexander H Schmidt; Soo Young Yang; Michelle Setterholm
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-13       Impact factor: 5.742

10.  Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow.

Authors:  Juliet N Barker; Timothy P Krepski; Todd E DeFor; Stella M Davies; John E Wagner; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2002       Impact factor: 5.742

View more
  20 in total

1.  Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.

Authors:  Scott R Solomon; Andrew St Martin; Mei-Jie Zhang; Karen Ballen; Asad Bashey; Minoo Battiwalla; Lee Ann Baxter-Lowe; Claudio Brunstein; Saurabh Chhabra; Miguel Angel Diaz Perez; Ephraim J Fuchs; Siddhartha Ganguly; Nancy Hardy; Peiman Hematti; Joseph McGuirk; Edward Peres; Olle Ringden; David Rizzieri; Rizwan Romee; Melhem Solh; David Szwajcer; Marjolein van der Poel; Edmund Waller; Basem M William; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2020-07-07       Impact factor: 5.742

2.  Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin.

Authors:  Ioannis Politikos; Jessica A Lavery; Patrick Hilden; Christina Cho; Taylor Borrill; Molly A Maloy; Sergio A Giralt; Marcel R M van den Brink; Miguel-Angel Perales; Juliet N Barker
Journal:  Blood Adv       Date:  2020-01-14

3.  Optimizing cord blood selection.

Authors:  Annalisa Ruggeri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

4.  High progression-free survival after intermediate intensity double unit cord blood transplantation in adults.

Authors:  Juliet N Barker; Sean M Devlin; Kristine A Naputo; Kelcey Skinner; Molly A Maloy; Lisa Flynn; Theodora Anagnostou; Scott T Avecilla; Andromachi Scaradavou; Christina Cho; Parastoo B Dahi; Sergio A Giralt; Boglarka Gyurkocza; Alan M Hanash; Katharine Hsu; Ann A Jakubowski; Esperanza B Papadopoulos; Jonathan U Peled; Miguel-Angel Perales; Craig S Sauter; Gunjan L Shah; Brian C Shaffer; Roni Tamari; James W Young; Mikhail Roshal; Richard J O'Reilly; Doris M Ponce; Ioannis Politikos
Journal:  Blood Adv       Date:  2020-12-08

5.  Increasing access to allogeneic hematopoietic cell transplant: an international perspective.

Authors:  Vanderson Rocha; Giancarlo Fatobene; Dietger Niederwieser
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 6.  Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics.

Authors:  Sanghee Hong; Navneet S Majhail
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

7.  Analysis of the CD34+ cell to total nucleated cell content ratio of 619 transplanted and back-up cord blood units.

Authors:  Ioannis Politikos; Christopher M Mazis; Kristine A Naputo; Kelcey Skinner; Melissa Nhaissi; Eric Davis; Andromachi Scaradavou; Juliet N Barker
Journal:  Bone Marrow Transplant       Date:  2020-08-29       Impact factor: 5.483

8.  Multimedia resources to support the recruitment of committed hematopoietic stem cell donors: Perspectives of the most-needed donors.

Authors:  Edward W Li; Anna Lee; Maryam Vaseghi-Shanjani; Alexander Anagnostopoulos; Gabriele Jagelaviciute; Elena Kum; Tanya Petraszko; Heidi Elmoazzen; David Allan; Warren Fingrut
Journal:  Transfusion       Date:  2020-12-02       Impact factor: 3.157

9.  Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC).

Authors:  Hanadi Rafii; Federico Garnier; Annalisa Ruggeri; Irina Ionescu; Caroline Ballot; Danièle Bensoussan; Christian Chabannon; Bernard Dazey; John De Vos; Eric Gautier; Christine Giraud; Jérome Larghero; Audrey Cras; Valérie Mialou; Virginie Persoons; Fabienne Pouthier; Jean-Baptiste Thibert; Jean-Hugues Dalle; Gerard Michel; Chantal Kenzey; Fernanda Volt; Vanderson Rocha; Jacques-Olivier Bay; Marie-Thérèse Rubio; Catherine Faucher; Evelyne Marry; Eliane Gluckman
Journal:  Bone Marrow Transplant       Date:  2021-05-14       Impact factor: 5.483

10.  Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis.

Authors:  Jason Dehn; Pintip Chitphakdithai; Bronwen E Shaw; Abby A McDonald; Steven M Devine; Linda J Burns; Stephen Spellman
Journal:  Transplant Cell Ther       Date:  2020-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.